These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23613251)

  • 21. Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
    Verma A; Degrado J; Hittelman AB; Wheeler MA; Kaimakliotis HZ; Weiss RM
    BJU Int; 2011 Apr; 107(7):1154-61. PubMed ID: 20735383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.
    Herrmann E; Eltze E; Bierer S; Köpke T; Görge T; Neumann J; Hertle L; Wülfing C
    Anticancer Res; 2007; 27(5A):3127-33. PubMed ID: 17970053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma.
    Tian D; Hu H; Sun Y; Tang Y; Lei M; Liu L; Han R; Wu C
    Mol Med Rep; 2015 Sep; 12(3):4522-4529. PubMed ID: 26129954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
    Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
    Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
    Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J; Zhang Y; Yao X; Wen K
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
    Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN
    Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
    Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
    Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
    Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
    Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W; Xu Z
    Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
    Theodoropoulos VE; Lazaris ACh; Sofras F; Gerzelis I; Tsoukala V; Ghikonti I; Manikas K; Kastriotis I
    Eur Urol; 2004 Aug; 46(2):200-8. PubMed ID: 15245814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of VEGF in urinary bladder transitional cell carcinoma in an Iraqi population subjected to depleted uranium: an immunohistochemical study.
    Al-Abbasi DS; Al-Janabi AA; Al-Toriahi KM; Jabor TA; Yasseen AA
    Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):307-11. PubMed ID: 19151604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.